Leptin by itself doesn't hold promise for weight loss — but a new mouse study suggests it could work in combination with ...
Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has outperformed its main competitor, Wegovy, in a clinical ...
Adults taking Zepbound lost 47% more weight on average than those taking Wegovy, according to clinical trial data from ...
Adults who take Zepbound lose more weight than those who take competitor weight loss drug Wegovy, according to new clinical ...
53mon MSN
Weight-loss meds go head-to-head in new study. One was significantly more effective, drugmaker says - In the first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback